Yu‐Shin Hung

1.7k total citations
104 papers, 1.2k citations indexed

About

Yu‐Shin Hung is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Yu‐Shin Hung has authored 104 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 22 papers in Surgery. Recurrent topics in Yu‐Shin Hung's work include Lymphoma Diagnosis and Treatment (22 papers), Frailty in Older Adults (21 papers) and Nutrition and Health in Aging (19 papers). Yu‐Shin Hung is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Frailty in Older Adults (21 papers) and Nutrition and Health in Aging (19 papers). Yu‐Shin Hung collaborates with scholars based in Taiwan, United States and United Kingdom. Yu‐Shin Hung's co-authors include Wen‐Chi Chou, Hung Chang, Po‐Nan Wang, Ming‐Chung Kuo, Jen‐Shi Chen, Jin‐Hou Wu, Chang‐Hsien Lu, Tzung‐Chih Tang, Chia‐Yen Hung and Kun‐Yun Yeh and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, American Journal of Kidney Diseases and The Journal of Pathology.

In The Last Decade

Yu‐Shin Hung

95 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu‐Shin Hung Taiwan	22	494	297	220	204	185	104	1.2k
Christopher Steer Australia	22	948 1.9×	367 1.2×	436 2.0×	190 0.9×	335 1.8×	89	2.2k
Nada Alachkar United States	23	120 0.2×	183 0.6×	260 1.2×	114 0.6×	430 2.3×	56	1.8k
Charles G. Newstead United Kingdom	19	373 0.8×	129 0.4×	140 0.6×	156 0.8×	314 1.7×	47	1.2k
Beatriz Korc‐Grodzicki United States	21	371 0.8×	194 0.7×	244 1.1×	42 0.2×	268 1.4×	78	1.5k
Nimit Singhal Australia	18	376 0.8×	78 0.3×	255 1.2×	50 0.2×	178 1.0×	69	1.0k
Pieter Heeren Belgium	13	448 0.9×	221 0.7×	359 1.6×	81 0.4×	355 1.9×	29	1.6k
Steven Oliver United Kingdom	19	396 0.8×	254 0.9×	318 1.4×	75 0.4×	98 0.5×	33	1.0k
Masakazu Ikenaga Japan	21	642 1.3×	197 0.7×	477 2.2×	159 0.8×	822 4.4×	185	1.8k
Dorin Colibaseanu United States	19	721 1.5×	137 0.5×	195 0.9×	103 0.5×	587 3.2×	92	1.3k
G Luporini Italy	15	887 1.8×	249 0.8×	510 2.3×	145 0.7×	405 2.2×	48	1.5k

Countries citing papers authored by Yu‐Shin Hung

Since Specialization

Citations

This map shows the geographic impact of Yu‐Shin Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Shin Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Shin Hung more than expected).

Fields of papers citing papers by Yu‐Shin Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Shin Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Shin Hung. The network helps show where Yu‐Shin Hung may publish in the future.

Co-authorship network of co-authors of Yu‐Shin Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Shin Hung. A scholar is included among the top collaborators of Yu‐Shin Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Shin Hung. Yu‐Shin Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Tung‐Liang, Yu‐Shin Hung, Hung Chang, et al.. (2025). Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas. Annals of Medicine. 57(1). 2478315–2478315.

Wang, Jialin, et al.. (2025). Association of Preoperative Frailty in Older Taiwanese Patients with Colorectal Cancer. Risk Management and Healthcare Policy. Volume 18. 2787–2797.

Hung, Yu‐Shin, Chia‐Yen Hung, & Wen-Chi Chou. (2024). Evaluating the cancer aging and research group model in predicting immunochemotherapy toxicity among elderly patients with diffuse large B-cell lymphoma. International Immunopharmacology. 138. 112544–112544. 1 indexed citations

Hung, Chia‐Yen, Mei‐Hui Hsu, Shu‐Hui Lee, et al.. (2024). Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT. Journal of the Formosan Medical Association. 123(9). 1010–1017. 2 indexed citations

Kuo, Ming‐Chung, Hung Chang, Jin‐Hou Wu, et al.. (2023). Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan. Clinical and Experimental Medicine. 23(8). 5327–5336. 1 indexed citations

Hsueh, William, Kun‐Yun Yeh, Yu‐Shin Hung, et al.. (2022). Albumin and Neutrophil-to-Lymphocyte Ratio Score in Neoadjuvant Concurrent Chemoradiotherapy for Esophageal Cancer: Comparison With Prognostic Nutritional Index. In Vivo. 36(5). 2400–2408. 7 indexed citations

Ho, Ya‐Wen, et al.. (2022). Optimal Frailty Dimensions for Assessing Frailty and Predicting Chemotherapy Adverse Events in Older Taiwanese Cancer Patients. Frontiers in Medicine. 9. 828865–828865. 3 indexed citations

Huang, Yung‐Hsin, Yu‐Shin Hung, Cheng-Chou Lai, et al.. (2021). Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy. Anticancer Research. 41(10). 5213–5222. 6 indexed citations

Lai, Cheng-Chou, Chia‐Yen Hung, Yu‐Ching Lin, et al.. (2021). A comparison of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer. Supportive Care in Cancer. 29(9). 5455–5462. 19 indexed citations

10.

Chuang, Wen‐Yu, et al.. (2020). Intravascular Large B-cell lymphoma: A case series and review of literatures. Biomedical Journal. 44(4). 479–488. 16 indexed citations

11.

Chou, Wen‐Chi, Pei‐Hung Chang, Ping‐Tsung Chen, et al.. (2020). Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). 602–611. 24 indexed citations

12.

Hung, Chia‐Yen, Cheng-Chou Lai, Ping‐Tsung Chen, et al.. (2018). Impact of body mass index on long-term survival outcome in Asian populations with solid cancer who underwent curative-intent surgery: A six-year multicenter observational cohort study. Journal of Cancer. 9(18). 3316–3325. 5 indexed citations

13.

Hung, Yu‐Shin, Chia‐Yen Hung, Chaohui Wang, et al.. (2017). Clinical characteristics and survival outcomes of terminally ill patients undergoing withdrawal of mechanical ventilation. Journal of the Formosan Medical Association. 117(9). 798–805. 8 indexed citations

14.

Hung, Yu‐Shin, Keng-Hao Liu, Chia‐Yen Hung, et al.. (2017). A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification. Asian Journal of Surgery. 42(1). 85–92. 17 indexed citations

15.

Chuang, Wen‐Yu, Hung Chang, Lee‐Yung Shih, et al.. (2015). CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(5). 571–582. 25 indexed citations

16.

Shih, Lee‐Yung, Hung Chang, Po‐Nan Wang, et al.. (2013). Clinical Features of Testicular Lymphoma. Acta Haematologica. 131(3). 187–192. 1 indexed citations

17.

Kao, Chen‐Yi, Yu‐Shin Hung, Po‐Jung Su, et al.. (2012). Validation of a Palliative Prognostic Index to Predict Life Expectancy for Terminally Ill Cancer Patients in a Hospice Consultation Setting in Taiwan. Asian Pacific Journal of Cancer Prevention. 13(6). 2861–2866. 27 indexed citations

18.

Lin, Tung‐Liang, Ming‐Chung Kuo, Lee‐Yung Shih, et al.. (2012). The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Annals of Hematology. 91(9). 1383–1391. 37 indexed citations

19.

Hung, Yu‐Shin, et al.. (2012). Potential benefits of palliative care for polysymptomatic patients with late-stage nonmalignant disease in Taiwan. Journal of the Formosan Medical Association. 112(7). 406–415. 10 indexed citations

20.

Lu, Chang‐Hsien, et al.. (2008). Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report. International Urology and Nephrology. 41(3). 567–570. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact